Callan Capital »

Takeda Pharmaceutical shares owned by Callan Capital

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Callan Capital from 13F filings

Historical chart of Callan Capital investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Callan Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Callan Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $192k 14k 14.27

More positions owned by Callan Capital

Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Schwab Strategic Tr Schwab Fdt Us Lg (FNDX)
Schwab Strategic Tr Schwb Fdt Int Lg (FNDF)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Invesco Exchange Traded Fd T Ftse Rafi 1000 (PRF)
Schwab Strategic Tr Schwab Fdt Us Bm (FNDB)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Apple (AAPL)
Ishares Tr Intl Eqty Factor (INTF)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Select Sector Spdr Tr Technology (XLK)
Spdr Ser Tr Portfoli S&p1500 (SPTM)

View all positions for Callan Capital

Top funds holding Takeda Pharmaceutical

Millennium Management
Goldman Sachs Group
Brandes Investment Partners
Arrowstreet Capital, Limited Partnership
Polygon Management
Managed Asset Portfolios
Van Eck Associates Corp.
Causeway Capital Management
Y.D. More Investments
Jane Street
Citadel Advisors
Bank of America Corporation
Wells Fargo & Company
Natixis Asset Management Advisors
Nomura Holdings

View all funds holding Takeda Pharmaceutical